Widespread horse-based mobility arose around 2200 BCE in Eurasia.

Horses revolutionized human history with fast mobility1. However, the timeline between their domestication and their widespread integration as a means of transport remains contentious2-4. Here we assemble a collection of 475 ancient horse genomes to assess the period when these animals were first reshaped by human agency in Eurasia. We find that reproductive control of the modern domestic lineage emerged around 2200 BCE, through close-kin mating and shortened generation times. Reproductive control emerged following a severe domestication bottleneck starting no earlier than approximately 2700 BCE, and coincided with a sudden expansion across Eurasia that ultimately resulted in the replacement of nearly every local horse lineage. This expansion marked the rise of widespread horse-based mobility in human history, which refutes the commonly held narrative of large horse herds accompanying the massive migration of steppe peoples across Europe around 3000 BCE and earlier3,5. Finally, we detect significantly shortened generation times at Botai around 3500 BCE, a settlement from central Asia associated with corrals and a subsistence economy centred on horses6,7. This supports local horse husbandry before the rise of modern domestic bloodlines.

Reassessing the Aurignacian of Slovenia: techno-economic behaviour and direct dating of osseous projectile points.

The Palaeolithic of southern Central Europe has a long history of archaeological research. Particularly, the presence of numerous osseous projectile points in many early Upper Palaeolithic (EUP) assemblages in this region has attracted the attention of the international research community. However, the scarcity of properly identified and well-dated Aurignacian contexts represents an obstacle for investigation of the nature and timing of the Middle to Upper Palaeolithic transition. In this context, the question of whether Neandertals made Aurignacian osseous projectile points, either on their own or as a consequence of cultural interaction with anatomically modern humans (AMH), still remains an open issue. Here we reassess the EUP record of Slovenia by evaluating the Aurignacian character of the assemblages from Potocka zijalka, Mokriska jama and Divje babe I in the light of their suggested roots in the local Mousterian. We provide a comprehensive description of the lithic industry from Potocka zijalka, which represents one of the rare EUP assemblages of southern Central Europe with a representative number of lithic artefacts to be analysed from the perspective of lithic technology and raw material economy. Our re-analysis of the Slovenian assemblages is backed by a series of 11 new ultrafiltered collagen 14C dates obtained directly on associated osseous projectile points from the studied assemblages. The Aurignacian of Potocka zijalka underlines the remarkable consistency of the Early Aurignacian with low typo-technological variability across Europe, resulting from a marked dependence on transported toolkits and raw material conservation. The new radiocarbon determinations for the Aurignacian of Slovenia appear to post-date the 34-32 ka BP (thousands of years before present) threshold for the last Neandertals in the region. Although not falsified, the hypothesis of Aurignacian bone tools in southern Central Europe as a product of late Neandertals is not supported by our re-examination of the EUP record of Slovenia.

Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.

PURPOSE: Since the advent of highly active antiretroviral therapy (HAART), the incidence of Kaposi's sarcoma (KS) among AIDS patients has declined both nationwide and in King County, Washington. We sought to compare clinical parameters of patients diagnosed with KS in the pre-HAART (1990 to 1996) and HAART (1997 to 2002) eras. METHODS: We used patient data abstracted from the Adult/Adolescent Spectrum of HIV-Related Diseases study of Public Health-Seattle and King County. RESULTS: Patients diagnosed with KS in the HAART era (n = 40) were significantly more likely (P < .05) than pre-HAART-era KS patients (n = 366) to be diagnosed with alcohol problems (43% v 18%), noninjection drug use (45% v 18%), injection drug use (25% v 10%), psychosis (25% v 13%), and hypertension (13% v 2%). Although median CD4(+) count and HIV-1 viral load at the time of KS diagnosis were not significantly different between the two groups, significantly fewer (P < .01) HAART-era KS patients developed opportunistic illnesses (OIs) during their follow-up. The risk of dying among KS patients diagnosed in the HAART era is significantly lower (P < .01) than for KS patients diagnosed in the pre-HAART era (hazard ratio, 0.24). CONCLUSION: Although HAART-era KS patients in King County were as likely to have a depleted CD4(+) cell count and high HIV-1 viral loads at the time of KS diagnosis as pre-HAART KS patients, they survived longer and fewer of them were diagnosed with other OIs. They also had an increased prevalence of substance abuse and mental illness, contributing to a dynamic and changing KS clinical profile.

The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy.

BACKGROUND: It has been suggested that sentinel lymph node (SLN) biopsy for breast cancer may be less accurate after excisional biopsy of the primary tumor compared with core needle biopsy. Furthermore, some have suggested an improved ability to identify the SLN when total mastectomy is performed compared with lumpectomy. This analysis was performed to determine the impact of the type of breast biopsy (needle vs. excisional) or definitive surgical procedure (lumpectomy vs. mastectomy) on the accuracy of SLN biopsy. METHODS: The University of Louisville Breast Cancer Sentinel Lymph Node Study is a prospective multi-institutional study. Patients with clinical stage T1-2, N0 breast cancer were eligible. All patients underwent SLN biopsy and completion level I/II axillary dissection. Statistical comparison was performed by chi(2) analysis. RESULTS: A total of 2206 patients were enrolled in the study. There were no statistically significant differences in SLN identification rate or false-negative rate between patients undergoing excisional versus needle biopsy. The SLN identification and false-negative rates also were not statistically different between patients who had total mastectomy compared with those who had a lumpectomy. CONCLUSIONS: Excisional biopsy does not significantly affect the accuracy of SLN biopsy, nor does the type of definitive surgical procedure.